1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. In-Vitro Diagnostics Quality Control Market, by Offering
6.1. Introduction
6.2. Data Management Solutions
6.3. Quality Assurance Services
6.4. Quality Control Products
6.4.1. Urine-Based Controls
6.4.2. Whole-Blood-Based Controls
6.4.3. Whole-Blood-Based Controls

7. In-Vitro Diagnostics Quality Control Market, by Distributor
7.1. Introduction
7.2. OEM
7.3. Third-Party Control Manufacturers
7.3.1. Independent Manufacturer Controls
7.3.2. Instrument-Specific Controls

8. In-Vitro Diagnostics Quality Control Market, by Application
8.1. Introduction
8.2. Clinical Chemistry
8.3. Coagulation or Hemostasis
8.4. Hematology
8.5. Immunochemistry
8.6. Microbiology
8.7. Molecular Diagnostics

9. In-Vitro Diagnostics Quality Control Market, by End User
9.1. Introduction
9.2. Clinical Laboratories
9.3. Hospitals
9.4. Research & Academic Institutes

10. California In-Vitro Diagnostics Quality Control Market

11. Florida In-Vitro Diagnostics Quality Control Market

12. Illinois In-Vitro Diagnostics Quality Control Market

13. New York In-Vitro Diagnostics Quality Control Market

14. Ohio In-Vitro Diagnostics Quality Control Market

15. Pennsylvania In-Vitro Diagnostics Quality Control Market

16. Texas In-Vitro Diagnostics Quality Control Market

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Abbott Laboratories Inc.
18.2. Bio-Rad Laboratories, Inc.
18.3. Helena Laboratories
18.4. Ortho Clinical Diagnostics, Inc.
18.5. Randox Laboratories Ltd
18.6. Roche Diagnostics
18.7. Seracare Life Sciences, Inc.
18.8. Sero as
18.9. Technopath Clinical Diagnostics
18.10. Thermo Fisher Scientific Inc.

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2026
FIGURE 7. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, 2018-2026 (USD MILLION)
FIGURE 14. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 15. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, 2018-2026 (USD MILLION)
FIGURE 16. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 17. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, 2018-2026 (USD MILLION)
FIGURE 18. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 19. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2020 VS 2026 (%)
FIGURE 20. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2020 VS 2026 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2026
FIGURE 22. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, 2018-2026 (USD MILLION)
FIGURE 23. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 24. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2026 (USD MILLION)
FIGURE 25. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 26. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, 2018-2026 (USD MILLION)
FIGURE 27. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 28. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, 2018-2026 (USD MILLION)
FIGURE 29. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 30. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 31. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2026
FIGURE 33. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2026 (USD MILLION)
FIGURE 34. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 35. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, 2018-2026 (USD MILLION)
FIGURE 36. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 37. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2026 (USD MILLION)
FIGURE 38. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 39. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, 2018-2026 (USD MILLION)
FIGURE 40. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 41. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2026 (USD MILLION)
FIGURE 42. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 43. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2026 (USD MILLION)
FIGURE 44. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 45. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 46. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2026
FIGURE 48. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2026 (USD MILLION)
FIGURE 49. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 50. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 51. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 52. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 53. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 54. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: FPNV POSITIONING MATRIX
FIGURE 55. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 56. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, BY STATE, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 25. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY STATE, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SCORES
TABLE 28. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: BUSINESS STRATEGY
TABLE 29. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: PRODUCT SATISFACTION
TABLE 30. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: RANKING
TABLE 31. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 32. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: MERGER & ACQUISITION
TABLE 33. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 34. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 35. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: INVESTMENT & FUNDING
TABLE 36. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 37. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories Inc.
Bio-Rad Laboratories, Inc.
Helena Laboratories
Ortho Clinical Diagnostics, Inc.
Randox Laboratories Ltd
Roche Diagnostics
Seracare Life Sciences, Inc.
Sero as
Technopath Clinical Diagnostics
Thermo Fisher Scientific Inc.